Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
concetta.potenza@uniroma1.it
Concetta Potenza
Professore Ordinario
Struttura:
DIPARTIMENTO DI SCIENZE E BIOTECNOLOGIE MEDICO-CHIRURGICHE
E-mail:
concetta.potenza@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
A case of twins affected by psoriasis, psoriatic arthritis and autism: Five years of efficacious and safe treatment with Secukinumab
DERMATOLOGIC THERAPY
2022
Guselkumab for the treatment of severe plaque psoriasis in a schizophrenia patient: a case report
DERMATOLOGY REPORTS
2022
Similar levels of efficacy of two different maintenance doses of adalimumab on clinical severity and quality of life of patients with hidradenitis suppurativa
JOURNAL OF CLINICAL MEDICINE
2022
A case report of Monkeypox in an adult patient from Italy: clinical and dermoscopic manifestations, diagnosis and management
VACCINES
2022
Herpes zoster ophthalmicus in two women after Pfizer-BioNTech (BNT162b2) vaccine
JOURNAL OF MEDICAL VIROLOGY
2022
Psoriatic patients with a history of cancer: A real-life experience with Apremilast treatment for 104 weeks
DERMATOLOGIC THERAPY
2022
HIV positive patient treated with ixekizumab
LA CLINICA TERAPEUTICA
2022
A case of proliferative nodule arising within blue nevus
LA CLINICA TERAPEUTICA
2022
Adverse skin reactions to personal protective equipment during COVID-19 pandemic in Italian health care workers
DERMATOLOGIC THERAPY
2022
The dermatological effects and occupational impacts of personal protective equipment on a large sample of healthcare workers during the COVID-19 pandemic
FRONTIERS IN PUBLIC HEALTH
2022
Long term efficacy, safety, and tolerability of tildrakizumab in epileptic patient with psoriasis and eczema
DERMATOLOGY REPORTS
2022
Comorbidities and treatment patterns in adult patients with atopic dermatitis: results from a nationwide multicenter study
ARCHIVES OF DERMATOLOGICAL RESEARCH
2022
Real-world outcomes in patients with moderate-to-severe plaque psoriasis treated with guselkumab for up to 1 year
EXPERT OPINION ON BIOLOGICAL THERAPY
2022
PSSD and biologic therapy: real-life data in 417 patients with moderate to severe psoriasis
REVIEWS ON RECENT CLINICAL TRIALS
2022
Safety and impact of anti-COVID-19 vaccines in psoriatic patients treated with biologics. A real life experience
JOURNAL OF CLINICAL MEDICINE
2021
How lockdown measures, during COVID-19 pandemic, matter on psoriatic patient’s perception. Study on 600 patients on biologic therapy
JOURNAL OF INFECTION AND PUBLIC HEALTH
2021
Long-term maintained response to selective internal radiation therapy in an oligometastatic uveal melanoma patient treated with concomitant Anti-PD-1 therapy
LIFE
2021
An open-label study comparing oral zinc to lymecycline in the treatment of acne vulgaris
THE JOURNAL OF CLINICAL AND AESTHETIC DERMATOLOGY
2021
Metastatic penile squamous cell carcinoma successfully treated with cemiplimab in an HIV patient
DERMATOLOGIC THERAPY
2021
Success of dupilumab as a monotherapy in an adult patient affected by severe uncontrolled asthma and atopic dermatitis
DERMATOLOGIC THERAPY
2021
« prima
< precedente
1
2
3
4
5
6
7
seguente ›
ultima »
ERC
LS4_1
LS4_6
Interessi di ricerca
Keywords
clinical trial
Progetti di Ricerca
Tumor microenvironment in melanoma treatment
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma